Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Study on the procoagulant characteristics of microparticles in acute myocardial infarction]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2024 | 39223887 | PubTator, text mining | PubMed |
| The trajectory of vesicular proteomic signatures from HBV-HCC by chitosan-magnetic bead-based separation and DIA-proteomic analysis. | J Extracell Vesicles | 2024 | 39207047 | PubTator, text mining | PubMed |
| [Exploring the Causal Relationship Between Coagulation Function and Gestational Diabetes Mellitus Through Mendelian Randomization]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2024 | 39170013 | PubTator, text mining | PubMed |
| The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects. | Expert Opin Investig Drugs | 2024 | 39166425 | PubTator, text mining | PubMed |
| Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo. | Blood | 2024 | 39158072 | PubTator, text mining | PubMed |
| The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension. | Clin Appl Thromb Hemost | 2024 | 39150410 | PubTator, text mining | PubMed |
| Impact of thyroid function on coagulation and venous thromboembolism: a two-sample mendelian randomization study. | J Thromb Thrombolysis | 2024 | 39110374 | PubTator, text mining | PubMed |
| Pharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data. | Clin Transl Sci | 2024 | 39082898 | PubTator, text mining | PubMed |
| Therapeutic Potential of FXI Inhibitors: Hype or Hope? | Drugs | 2024 | 39073551 | PubTator, text mining | PubMed |
| Will Factor XI Inhibitors Replace Current Anticoagulants for Stroke Prevention in Atrial Fibrillation? | Curr Cardiol Rep | 2024 | 39042343 | PubTator, text mining | PubMed |
| Diagnosis and management of factor XI alloinhibitors in patients with congenital factor XI deficiency-A large single-centre experience. | Haemophilia | 2024 | 39039722 | PubTator, text mining | PubMed |
| Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants. | Sci Rep | 2024 | 39025971 | PubTator, text mining | PubMed |
| Perioperative management and neuraxial analgesia in women with factor XI deficiency (<60 IU/dL): a French multicenter observational study of 314 pregnancies. | Res Pract Thromb Haemost | 2024 | 39006229 | PubTator, text mining | PubMed |
| Factor XI inhibition in cardiovascular disease. | Pol Arch Intern Med | 2024 | 38984712 | PubTator, text mining | PubMed |
| Elevated plasma factor XI is associated with postthrombotic syndrome. | Thromb Res | 2024 | 38968817 | PubTator, text mining | PubMed |
| Real world management of individuals with severe FXI deficiency and its impact on clinical outcomes: Experience from a haemophilia treatment centre. | Haemophilia | 2024 | 38951042 | PubTator, text mining | PubMed |
| Quantification of the contribution of individual coagulation factors to haemostasis using a microchip flow chamber system and reconstituted blood from deficient plasma. | Vox Sang | 2024 | 38950904 | PubTator, text mining | PubMed |
| Coagulation factor XI relative to established cardiovascular risk factors and atherosclerosis, in a large middle-aged population. | Thromb Res | 2024 | 38944019 | PubTator, text mining | PubMed |
| APTT critical value establishment in four different reagent/instrument systems based on single factor deficiencies. | Ann Hematol | 2024 | 38935318 | PubTator, text mining | PubMed |
| Enhancing Oral Bioavailability of Simvastatin Using Uncoated and Polymer-Coated Solid Lipid Nanoparticles. | Pharmaceutics | 2024 | 38931885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=11